The use of USPIO enhanced MRI in the assessment of axillary lymph node status in patients with invasive breast cancer
- Conditions
- lymph node metastasistumor positive lymph nodes10006291
- Registration Number
- NL-OMON30564
- Lead Sponsor
- niversitair Medisch Centrum Sint Radboud
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Not specified
- Target Recruitment
- 440
- Histologically proven invasive breast cancer
- Surgical removal of at least 1 axillary lymph node will be performed
- Patient must be accessible for treatment
- Patient must provide written informed consent
- Patient age < 18
- Karnofsky score = 70 or <70
- Pregnant or lactating women
- Patients with conta-indications for MRI scanning (e.g. pacemaker, claustrophobia, ferromagnetic objects in the eyes or brain)
- Patients with contra-indications for the use of USPIO based contrast agents or dextran (e.g. known allergy)
- Male gender
Study & Design
- Study Type
- Observational invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>The primary endpoint is the sensitivity of MRL for proved lymph node<br /><br>involvement by histopathology on a patient to patient basis</p><br>
- Secondary Outcome Measures
Name Time Method <p>· Sensitivity on a node to node basis<br /><br>· Specificity, accuracy, negative predictive value and positive predictive<br /><br>value on a patient to patient and node to node basis<br /><br>· Posttest probability negative rate<br /><br>· Feasibility of MRL after SLNB<br /><br>· Diagnostic accuracy of MRL after SLNB<br /><br>· Prognostic value of IMN involvement<br /><br>· Prognostic value of positive and negative MRL after positive SLNB followed by<br /><br>irradiation of the axilla<br /><br>· Feasibility of MRL after neoadjuvant chemotherapy<br /><br>· Diagnostic accuracy of MRL after neoadjuvant chemotherapy<br /><br>· Effect of chemotherapy on tumor positive axillary lymph nodes</p><br>